In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stratec Medical

Latest From Stratec Medical

The Lonely World of European Device Start-Ups

Because of a conservative clinical culture and a skittish venture community, medical-device company creation has lagged in Europe. The reasons for the lack of device company creation are several: a physician community that is not only not entrepreneurial, but often averse to capitalizing on commercial opportunities; a venture capital community unfamiliar with devices; and a lack of

Medical Device Europe

IsoTis BV

Uniting engineering with biology is the aim of IsoTis BV. The start-up has a portfolio of 33 patents all related to what the company terms "substitution medicine", the replacement or repair of human tissue.

Medical Device Strategy

Implex Corp.

Orthopedic Implants. Implex is using an advanced biomaterial called {Hedrocel} in devices for a variety of musculoskeletal applications. {Hedrocel} has excellent biocompatibility, mechanical properties approximating those of human bone, and providesthe body with an "open cell" scaffold through which bone and other living tissue may grow.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices